↓ Skip to main content

Small-Molecule Inhibitors of USP1 Target ID1 Degradation in Leukemic Cells

Overview of attention for article published in Molecular Cancer Therapeutics, December 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

patent
11 patents

Citations

dimensions_citation
140 Dimensions

Readers on

mendeley
80 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Small-Molecule Inhibitors of USP1 Target ID1 Degradation in Leukemic Cells
Published in
Molecular Cancer Therapeutics, December 2013
DOI 10.1158/1535-7163.mct-13-0103-t
Pubmed ID
Authors

Helena Mistry, Grace Hsieh, Sara J. Buhrlage, Min Huang, Eunmi Park, Gregory D. Cuny, Ilene Galinsky, Richard M. Stone, Nathanael S. Gray, Alan D. D'Andrea, Kalindi Parmar

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 80 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 25%
Student > Ph. D. Student 12 15%
Student > Master 10 13%
Student > Bachelor 8 10%
Other 5 6%
Other 13 16%
Unknown 12 15%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 27 34%
Agricultural and Biological Sciences 20 25%
Pharmacology, Toxicology and Pharmaceutical Science 9 11%
Chemistry 5 6%
Medicine and Dentistry 4 5%
Other 3 4%
Unknown 12 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 November 2023.
All research outputs
#3,881,305
of 25,784,004 outputs
Outputs from Molecular Cancer Therapeutics
#604
of 4,094 outputs
Outputs of similar age
#42,594
of 322,371 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#18
of 94 outputs
Altmetric has tracked 25,784,004 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,094 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 322,371 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 94 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.